-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Equal-Weight on Oscar Health, Raises Price Target to $21

Benzinga·05/07/2026 16:47:16
Listen to the news
Barclays analyst Andrew Mok maintains Oscar Health (NYSE:OSCR) with a Equal-Weight and raises the price target from $18 to $21.